USPTO serial 79400970
MERCK SHARP & DOHME
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 30, 2026
- Examiner
- MCNAMARA, SHANA MARIE
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with MERCK SHARP & DOHME?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christina S. Loza
Christina S. Loza LOZA & LOZA, LLP305 N. Second Ave., #127Upland, CA 91786United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, urological, autoimmune, fungal, bacterial, parasitic diseases and disorders for human and veterinary use; vaccines for human and veterinary use; medicinal, pharmaceutical, therapeutic, and biological preparations for internal use and topical use for the treatment of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, urological, autoimmune, fungal, bacterial, parasitic diseases and disorders; medicated supplements for foodstuffs for animals; drug delivery patches, namely, transdermal patches for use in the treatment of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, urological, autoimmune, fungal, bacterial, parasitic diseases and disorders | ACTIVE | — |
| 009 | Downloadable software and computer hardware for collecting, monitoring, analyzing, managing, processing, sharing and accessing patient health, medical, diagnostic, and healthcare data; downloadable software for use in the preparation and testing of pharmaceuticals; electronic downloadable publications in the nature of journal articles, press releases, fact sheets, data sheets, brochures, image files, manuals, guides, and reports in the fields of healthcare, pharmaceuticals, medicine, and animal health; downloadable software for providing information in the fields of healthcare, pharmaceuticals, medicine, and animal health; downloadable computer software for use in inventory, shipment and delivery management in the fields of healthcare, pharmaceuticals, medicine, and animal health; downloadable software and computer hardware for collecting, tracking, monitoring, analyzing, managing, processing, sharing and accessing information and data in the fields of animals and agriculture; radio-frequency identification (RFID) and electronic encoded identity tags for use in identifying and monitoring animals; electronic animal identification apparatus; microchips for use in animals | ACTIVE | — |
| 010 | Surgical apparatus and instruments for medical or veterinary use; medical instruments and apparatus for diagnosing and treating autoimmune, bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, infectious and urological diseases and disorders; inhalers for medical purposes, sold empty; injection and medical or veterinary infusion devices for administering pharmaceuticals; veterinary apparatus and instruments for dispensing pharmaceutical products, namely, drenching guns for animals and livestock, veterinary vaccine applicators, veterinary infusers and injectors, veterinary dosing devices, sutures, and temperature measuring systems for veterinary use | ACTIVE | — |
| 035 | Business support services to start-up companies in the pharmaceutical, healthcare, veterinary, and biomedical fields by providing workspace containing technology equipment; business information services in the fields of healthcare, pharmaceuticals, medicine, and animal health; providing incentive award programs through issuance and processing of loyalty points for purchase of a company's goods and services in the fields of healthcare, pharmaceuticals, medicine, and animal health; administration of a program for enabling participants to obtain discounts on products and services in the fields of healthcare, pharmaceuticals, medicine, and animal health; provision of business, marketing, product sales and commercial information relating to pharmaceutical, medical, veterinary and healthcare products via a global communications network; retail, wholesale, and online retail store services featuring vaccines, pharmaceuticals, healthcare products, medicines, and veterinary products; distribution of advertising, marketing and promotional material in the fields of healthcare, pharmaceuticals, medicines, and animal health; business research and data analysis in the field of pharmaceutical drug development | ACTIVE | — |
| 041 | Educational services, namely, conducting programs in the fields of medicine, healthcare, pharmaceuticals, and animal health, and distribution of educational materials in connection therewith. | ACTIVE | — |
| 042 | Providing medical research information in the fields of pharmaceuticals, clinical trials, and veterinary preparations; medical, scientific, veterinary, and pharmaceutical research and development services; design and development of computer hardware and software in the fields of healthcare, pharmaceuticals, medicines, and animal health; medical and scientific research, namely conducting clinical trials for others; providing online non-downloadable software for collecting, monitoring, analyzing, managing, processing, sharing and accessing patient health, medical, diagnostic, and healthcare data; providing online non-downloadable software for use in the preparation and testing of pharmaceuticals; providing online non-downloadable software for providing information in the fields of healthcare, pharmaceuticals, medicines, and animal health; providing online non-downloadable software for use in inventory, shipment and delivery management in the fields of healthcare, pharmaceuticals, medicines, and animal health; providing online non-downloadable software for collecting, tracking, monitoring, analyzing, managing, processing, sharing and accessing information and data in the fields of animals and agriculture | ACTIVE | — |
| 044 | Providing information in the fields of healthcare, pharmaceuticals, medicines, and animal health, including via a website; charitable services, namely, providing medical, veterinary and healthcare services in the nature of providing medication use and management information and mental health and wellness information to patients and caregivers; veterinary services; medical testing for diagnostic or treatment purposes; medical analysis services relating to the treatment and diagnosis of patients | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Merck Sharp & Dohme B.V.
- Other trademarks owned by Merck Sharp & Dohme B.V.
- Other trademarks owned by Merck Sharp & Dohme B.V.
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named MERCK SHARP & DOHME
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 30, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 20, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 30, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 30, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 12, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 12, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 6, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 15, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 14, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 14, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 14, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 10, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 10, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 10, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 8, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Dec 24, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 24, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Nov 17, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 17, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 17, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 12, 2025 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jul 29, 2025 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jun 27, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 27, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 27, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 27, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 27, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 27, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 27, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 27, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 9, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 22, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 22, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 25, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 24, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 18, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 29, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 29, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 25, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |